Company / Cash per Share
Enveric Biosciences, Inc. Cash per Share History
FY2017-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.81
FY2019
5-year range
$0.08 / $0.81
FY2017-FY2019
Trend
+972.7%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +973% YoY in FY2019, a notable deviation from the 2-year average annual change of +474%.
Based on SEC 10-K filings.
0.81 in FY2019.
Improved from $0.10 to $0.81 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, cash per share increased 972.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $0.81 | +972.7% |
| FY2018 | $0.08 | -24.0% |
| FY2017 | $0.10 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026